Form D · Pharmaceuticals
ING PHARMA LLC
Indianapolis, IN · CIK 0001510840
Offering snapshot reported Jan 21, 2011 · SEC filing
- Reported sold
- $616K Offering amount: $616K
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $12.5K Reported outside-investor minimum
- First sale
- Jan 30, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 21, 2011 | Initial | $615,500 | No comparison | 25 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-154199
Source: Form D, filed Jan 21, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eric Potts, M.D. | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
8333 Naab Road Suite 250
Indianapolis, IN, 46260
Indianapolis, IN, 46260